is an alliance of independent organizations around the world dedicated to accelerating the development of a preventive HIV vaccine by:
- A shared Scientific Strategic Plan: Implementing a strategic plan for HIV vaccine research that spans vaccine discovery to development and access
- Increased resources: Mobilizing significant new funding to achieve the Scientific Strategic Plan and grow the field of HIV vaccine research and development
- Greater collaboration: In keeping with the intent of the Scientific Strategic Plan, promoting more efficient, faster ways for researchers to share successes and failures and avoid duplication of efforts
The Enterprise has the unique convening power to bring together an inclusive global alliance of top researchers, funders, advocacy groups, and stakeholders to catalyze fresh thinking, set new directions, and advance global cooperation to develop a preventive HIV vaccine.